Navigating the procurement of synthetic peptide bioregulators requires absolute analytical verification and strict lot-to-lot consistency. PX1 Research serves as a trusted domestic partner for institutional investigators studying the vascular, cerebral, and gene-regulatory properties of Cortagen in laboratory models.
Navigating the procurement of synthetic peptide bioregulators requires absolute analytical verification and strict lot-to-lot consistency. PX1 Research serves as a trusted domestic partner for institutional investigators studying the vascular, cerebral, and gene-regulatory properties of Cortagen in laboratory models.
When sourcing Cortagen for hemodynamics and vascular research, selecting a verified blood pressure Cortagen supplier requires rigorous validation. PX1 Research provides USA-manufactured Cortagen (Ala-Glu-Asp-Pro) engineered specifically for laboratory research use only. Every lot undergoes independent ISO 17025 third-party testing, including RP-HPLC purity verification (>99%), mass spectrometry structure confirmation, and quantitative endotoxin analysis.
Investigators conducting advanced in vitro and animal assays require standardized compounds free from TFA salt contamination, unreacted amino acid fragments, and microbial pyrogens. By maintaining strict cleanroom synthesis standards and direct domestic dispatch from California and Arizona facilities, PX1 Research eliminates supply chain ambiguity for academic and corporate research laboratories.
Cortagen is a synthetic tetrapeptide with the primary amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-L-proline (Ala-Glu-Asp-Pro). Belonging to the class of short-chain Khavinson peptide bioregulators, Cortagen was originally modeled after endogenous tissue extracts isolated from the brain cortex. Research into khavinson peptides overview demonstrates that these short peptide sequences can penetrate cell membranes, translocate to the nucleus, and interact directly with specific histone proteins and DNA promoter regions.
In structural biology models, the Ala-Glu-Asp-Pro sequence exhibits high conformational stability despite its small molecular weight (approx. 444.4 g/mol). This compactness facilitates electrostatic interaction with the minor groove of double-stranded DNA. Preclinical data indicate that this sequence selective binding modulates chromatin structure, thereby altering transcriptional activity without inducing permanent genomic modifications.
The primary interest in Cortagen within cardiovascular and neurovascular literature stems from its observed capacity to influence vascular tone, endothelial integrity, and stress-induced hemodynamic fluctuations. Preclinical rodent models investigating arterial hypertension and ischemic injury have examined how Cortagen administration impacts expression patterns of nitric oxide synthase (NOS) enzymes, particularly endothelial NOS (eNOS).
In vitro endothelial cell culture assays suggest that Cortagen upregulates localized eNOS transcription, fostering balanced nitric oxide production necessary for vascular smooth muscle relaxation. Furthermore, animal studies assessing central nervous system ischemia demonstrate that Cortagen application correlates with decreased inflammatory cytokine expression (such as IL-1β and TNF-α) in cerebral vascular walls. This dual action—supporting vascular autoregulation and mitigating oxidative stress—makes Cortagen a key candidate for experimental models evaluating blood pressure regulation and cerebral blood flow.
Extensive Soviet and contemporary Eastern European biomedical literature has detailed the physiological effects of Cortagen across various pathological models. In normotensive and spontaneously hypertensive rat (SHR) models, researchers observed that peptide administration resulted in a stabilizing effect on mean arterial pressure under acute stress conditions. These observations suggest that Cortagen does not act as a direct vasodilator or acute hypotensive pharmacological agent, but rather as an epigenetic regulator restoring physiological homeostasis.
In non-human primate studies examining age-related vascular stiffness and metabolic decline, short-chain bioregulators demonstrated a normalizing influence on circadian lipid profiles and systemic blood pressure parameters. Preclinical evidence indicates that the peptide acts upstream of classical receptor pathways, modulating gene networks involved in antioxidant defense (e.g., superoxide dismutase, catalase) and tissue repair. Researchers can review detailed mechanistic papers in our broader research library hub.
To properly contextualize Cortagen within vascular and neurological research, investigators often compare its profile to other synthetic Khavinson peptides. While Cortagen specifically targets cortical and vascular gene networks, compounds like Epitalon operate primarily on pineal gland function and telomerase activity. Similarly, Pinealon focuses on neuroprotection against hypoxia, and Vilon exhibits pronounced immunomodulatory and fibroblast-regulatory properties.
Understanding these functional distinctions is critical when designing multi-compound experimental arms. The following matrix contrasts Cortagen against comparable short-chain peptides frequently utilized in cardiovascular and systemic homeostasis assays:
Cortagen (Ala-Glu-Asp-Pro): Primary target tissue includes brain cortex and vascular endothelium. Mechanistic focus centers on eNOS expression, neurovascular protection, and stress-induced blood pressure stabilization.
Epitalon (Ala-Glu-Asp-Gly): Primary target tissue includes the pineal gland and neuroendocrine axis. Mechanistic focus centers on telomerase activation, melatonin synthesis regulation, and systemic lifespan extension in rodent models.
Pinealon (Glu-Asp-Arg): Primary target tissue includes central nervous system neurons. Mechanistic focus centers on reactive oxygen species (ROS) reduction, anti-apoptotic signaling, and cognitive preservation under hypoxic stress.
Vilon (Lys-Glu): Primary target tissue includes splenocytes and immune populations. Mechanistic focus centers on chromatin unfolding in lymphocytes, T-cell reactivation, and wound healing kinetics.
For complex protocols examining broader vascular systems, investigators often consult our dedicated analysis on peptides for vascular biology to select the optimal molecular tools.
Assaying short peptides requires highly sensitive analytical equipment because minor impurities can significantly distort cell culture responses and binding assays. When choosing a blood pressure Cortagen supplier, research institutions must enforce stringent criteria regarding analytical documentation.
Every batch of Cortagen supplied by PX1 Research undergoes rigorous testing in an ISO 17025 accredited laboratory. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) ensures a chemical purity threshold exceeding 99.0%, eliminating truncated peptide sequences. Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass of the Ala-Glu-Asp-Pro construct. Furthermore, Chromogenic Recombinant Limulus Amebocyte Lysate (rLAL) testing guarantees endotoxin levels remain strictly below <0.01 EU/mg, preventing unspecific inflammatory responses in sensitive cell lines or animal tissues.
Cortagen is delivered as a lyophilized (freeze-dried) sterile powder to preserve chemical integrity during transit. Upon receipt, lyophilized vials should be stored at -20°C or -80°C for long-term stability. Exposure to light and thermal fluctuations should be minimized.
For reconstitution in laboratory settings, researchers should use sterile Bacteriostatic Water or Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream assay. Gently introduce the solvent along the inner glass wall of the vial and allow the lyophilizate to dissolve without aggressive vortexing, which can introduce shear stress. Reconstituted liquid aliquots should be stored at 4°C for immediate use within 48 to 72 hours, or snap-frozen at -80°C for extended experimental runs. Avoid repeated freeze-thaw cycles.
PX1 Research supports high-throughput screening projects, university research laboratories, and biotechnology firms requiring consistent batch availability. Institutional procurement teams can establish streamlined purchasing via our wholesale lab account portal to secure dedicated lot reservation, custom vial configurations, and volume pricing structures.
All shipments originate from our centralized USA distribution centers in California and Arizona, ensuring fast domestic transit times and compliant cold-chain packaging when required. By maintaining complete lot traceability from synthesis to delivery, PX1 Research provides the analytical confidence required for reproducible preclinical investigation.
What is the primary target mechanism of Cortagen in blood pressure research?
Preclinical studies suggest Cortagen influences blood pressure regulation by modulating gene expression in the vascular endothelium—specifically upregulating endothelial nitric oxide synthase (eNOS)—and reducing oxidative stress markers in neurovascular walls during acute physiological stress.
How is the purity of Cortagen verified by PX1 Research?
PX1 Research verifies every lot using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity (>99%) and Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight confirmation. Endotoxin levels are independently tested via rLAL assays to ensure <0.01 EU/mg.
Is Cortagen approved for human therapeutic use or blood pressure treatment?
No. Cortagen provided by PX1 Research is supplied strictly for laboratory research use only (RUO). It is not approved by the FDA for human consumption, therapeutic treatment, or medical diagnosis.
What solvent is recommended for reconstituting lyophilized Cortagen in vitro?
For standard laboratory assays, sterile Phosphate-Buffered Saline (PBS, pH 7.4) or sterile Bacteriostatic Water is recommended. Solvent choice should be tailored to your specific cellular or enzymatic assay protocol.
How does Cortagen differ from Epitalon and Pinealon?
Cortagen (Ala-Glu-Asp-Pro) primarily targets vascular endothelium and cerebral cortex gene networks. Epitalon (Ala-Glu-Asp-Gly) targets pineal gland activity and telomerase, while Pinealon (Glu-Asp-Arg) targets neuronal protection against hypoxic damage.
What storage conditions maintain the longest stability for Cortagen?
Lyophilized Cortagen powder should be stored at -20°C or -80°C in a dry, dark environment. Once reconstituted, solution aliquots should be kept at -80°C to prevent peptide degradation over time.
Can institutions purchase bulk quantities of Cortagen for long-term studies?
Yes. Qualified academic and commercial laboratories can open institutional accounts through PX1 Research to reserve specific synthesis lots, order bulk milligram/gram quantities, and request custom certificate-of-analysis documentation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.